StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.33−0.19 (-12.76%)

Close on Nov 18, 2026Market cap $21.75MP/E –Yield –

Cellyan Biotechnology operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2026 it was -$2.39M.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$2.39M–
FY2025Mar 31, 2025-$2.28M–
FY2024Mar 31, 2024-$1.95M–
FY2023Mar 31, 2023-$1.79M–

More Cellyan Biotechnology figures

See a number that looks wrong?